What is Roivant Sciences's share buybacks?

Roivant Sciences (ROIV) reported share buybacks of $208.29M in Q2 2025.

How has Roivant Sciences's share buybacks changed year-over-year?

Roivant Sciences's share buybacks decreased by 67.9% year-over-year, from $648.39M to $208.29M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Roivant Sciences ROIV Share Buybacks

Share Buybacks at other companies

AbbVieABBV

$1.49B+54.9%

RevvityRVTY

$86.5M-43.7%

Other financials

Income statement

See full

Revenue$2.5M-66.7%

Operating income-$339.2M-23.6%

Net income-$265.9M-257%

EPS (diluted)-$0.38-265%

Balance sheet

See full

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total equity$4.5B-3.4%

Total assets$5.7B+5.0%

Cash flow

See full

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Valuation

See full

Market cap$25.25B+226%

Enterprise value$23.93B+209%

P/S3,056.5×+2,723×

Profitability

See full

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

FCF margin-9,183.5%-17,093pp

Returns & leverage

See full

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Roivant Sciences’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Roivant Sciences's share buybacks?: Roivant Sciences (ROIV) reported share buybacks of $208.29M in Q2 2025.
How has Roivant Sciences's share buybacks changed year-over-year?: Roivant Sciences's share buybacks decreased by 67.9% year-over-year, from $648.39M to $208.29M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.